Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Feb;165(2):61-71.
doi: 10.1007/s11046-007-9081-0. Epub 2007 Nov 23.

Asymptomatic dermatophyte scalp carriage: laboratory diagnosis, epidemiology and management

Affiliations
Review

Asymptomatic dermatophyte scalp carriage: laboratory diagnosis, epidemiology and management

Macit Ilkit et al. Mycopathologia. 2008 Feb.

Abstract

Asymptomatic carrier is defined as an individual who has dermatophyte-positive scalp culture without signs or symptoms of tinea capitis. The prevalence of asymptomatic carriage differs from region to region with a rate of 0.1-49%. Anthropophilic dermatophytes, Trichophyton tonsurans and Trichophyton violaceum, have been generally associated with high rates of asymptomatic carriage. Hence, the presence of dermatophytes on healthy scalp hairs of children may be a potential source of infection for schoolmates, playmates and/or households. Although it was also reported in adults, most carriage has been observed in children especially among those between 4 and 8 years of age, while male to female ratios vary between studies. It is still unclear, whether carriers should be treated with topical antifungal shampoos or oral antifungals or both, as some studies indicate that some untreated cases become culture-negative after 2-12 months. This review provides details on related dermatophyte fungi, laboratory diagnosis, epidemiology, ways of spreading as well as treatment and follow-up results of asymptomatic carriage. An integration into the school health programs is proposed, which will render the possible dealing of the subject in a comprehensive and reasonable manner.

PubMed Disclaimer

References

    1. Br J Dermatol. 1966 Apr;78(4):219-21 - PubMed
    1. Pediatrics. 1992 Sep;90(3):416-8 - PubMed
    1. Pediatrics. 2006 Dec;118(6):2365-73 - PubMed
    1. Pediatr Infect Dis J. 2005 Aug;24(8):749-50 - PubMed
    1. Mycopathologia. 1990 Feb;109(2):69-73 - PubMed

LinkOut - more resources